Elekta
| Type | Public |
|---|---|
| Nasdaq Stockholm: EKTA B | |
| Industry | Neuroscience Radiation therapy Radiosurgery Oncology Electronic medical record |
| Founded | 1972 |
| Founder | Lars Leksell, Laurent Leksell |
| Headquarters | , Sweden |
Number of locations | Elekta has offices in more than 40 countries. Primary locations include: Stockholm, Crawley, Veenendaal, Warsaw, Helsinki, Milan, Cairo, Istanbul, New Delhi, Seoul, Beijing, Shanghai, Hong Kong, Tokyo, Sydney, San Jose, California, Atlanta, Montreal, Mexico City, São Paulo |
| Key people | Jakob Just-Bomholt, President and CEO |
| Products | Elekta Unity MR-Linac, Leksell Gamma Knife, Versa HD linear accelerator, Evo linear accelerator, Harmony linear accelerator, Brachytherapy products; as well as Oncology Information System (MOSAIQ), Treatment Planning Software (Monaco) |
| -517 million SEK | |
Number of employees | 4,100 |
| Website | www |
Elekta is a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders. The company has an installed base of approximately 7,500 devices and software solutions worldwide. Each year more than 2 million patients are treated using Elekta solutions across 130 countries. Elekta is headquartered in Stockholm, Sweden, with over 4,000 employees and offices in more than 40 countries. The company is listed on Nasdaq Stockholm.